WEBINARS
PRESENTED BY: FRANCESCA TRIVELLONI (CEFIC), TOMASZ SOBANSKI (EUROPEAN CHEMICALS AGENY), MARK VIANT (UNIVERSITY OF BIRMINGHAM / MICHABO HEALTH SCIENCE LTD), ANTHONY REARDON (HEALTH CANADA), TOM LAWSON (MICHABO HEALTH SCIENCE LTD)
This webinar explored how omics bioactivity data can be used to increase confidence in chemical grouping. It includes both regulatory and industry perspectives, highlighting the importance of grouping to support read-across and to enable a reduction in animal testing. The session featured several case studies demonstrating the application of metabolomics and transcriptomics data in chemical grouping. The session also introduced some emerging guidance being developed by the OECD to report omics-based grouping studies. Finally, a case study was presented that expands beyond the primary use of metabolomics, here being used to discover chemical biotransformation products which can then be used to support chemical grouping based on metabolic similarity.
